|
RPN1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.591200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.790800E-01 |
| Normal-vs-Stage2 |
5.283000E-01 |
| Normal-vs-Stage3 |
3.669600E-01 |
| Normal-vs-Stage4 |
2.958800E-01 |
| Stage1-vs-Stage2 |
9.628400E-01 |
| Stage1-vs-Stage3 |
9.595600E-01 |
| Stage1-vs-Stage4 |
7.085800E-02 |
| Stage2-vs-Stage3 |
9.891600E-01 |
| Stage2-vs-Stage4 |
1.931350E-01 |
| Stage3-vs-Stage4 |
9.293700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.331400E-01 |
| Normal-vs-AfricanAmerican |
1.137960E-01 |
| Normal-vs-Asian |
7.036400E-01 |
| Caucasian-vs-AfricanAmerican |
1.985030E-01 |
| Caucasian-vs-Asian |
8.987800E-01 |
| AfricanAmerican-vs-Asian |
6.859000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.215800E-02 |
| Normal-vs-Female |
6.072500E-02 |
| Male-vs-Female |
1.84820999999946E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.542000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.320200E-01 |
| Normal-vs-Age(61-80Yrs) |
3.452600E-01 |
| Normal-vs-Age(81-100Yrs) |
3.866300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.785400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.641400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.286420E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.286800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.821640E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.879200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.906800E-01 |
| Normal-vs-Grade 2 |
1.457570E-01 |
| Normal-vs-Grade 3 |
4.888800E-01 |
| Normal-vs-Grade 4 |
3.147600E-01 |
| Grade 1-vs-Grade 2 |
4.043200E-01 |
| Grade 1-vs-Grade 3 |
4.512600E-01 |
| Grade 1-vs-Grade 4 |
6.971000E-01 |
| Grade 2-vs-Grade 3 |
4.962600E-01 |
| Grade 2-vs-Grade 4 |
5.362400E-02 |
| Grade 3-vs-Grade 4 |
1.250780E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.648210E-01 |
| Normal-vs-ccB subtype |
6.530800E-01 |
| ccA subtype-vs-ccB subtype |
8.360000E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.814200E-01 |
| Normal-vs-N1 |
9.025700E-02 |
| N0-vs-N1 |
3.292500E-02 |
|
|
